Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Clinical TrialClinical Development

PUBLISHER: Visiongain Reports Ltd. | PRODUCT CODE: 1211753

Cover Image

PUBLISHER: Visiongain Reports Ltd. | PRODUCT CODE: 1211753

Clinical Trial Supplies Market Report 2023-2033

PUBLISHED:
PAGES: 423 Pages
DELIVERY TIME: 1-2 business days
Get a Free Sample
Get More Info
SELECT AN OPTION
Unprintable PDF (Single User) - 1 Year License
USD 4938
PDF (Team License - Up to 6 Users) - 1 Year License
USD 5625
PDF (Site License)
USD 6875
PDF (Enterprise License - Includes Free Datasets)
USD 8688

Add to Cart

Contact us about how to customize the report with add-on data.

Description

Table of Contents

List of Tables

The global Clinical Trial Supplies market is projected to grow at a CAGR of 9.32% by 2033.

“The Clinical Trial Supplies Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increasing Demand for Clinical Trial Outsourcing is driving the Demand for Clinical Trial Supplies Market

Downsizing and cost-cutting are important factors for large and mid-size pharmaceutical companies to outsource clinical trials, as CRO expertise in a specific therapeutic in a market where the company lacks experience with regulatory processes, operational expertise, and the ability to use manpower for other activities at the time of increasing workload. Furthermore, due to the increasing process complexity and cost of clinical studies, pharmaceutical manufacturers have been forced to outsource clinical trial supplies and supply them to research sites for reducing cost and time. Clinical supply firms are concentrating on data sharing to assist them build a solid supply chain for clinical consumables during clinical trials. This factor will have a favourable impact on the revenue growth of the clinical trial supplies market throughout the forecast period.

Unavailability of Storage Facilities in across Multiple Nations May Hamper the Expansion Clinical Trial Supplies Market

Certain clinical materials must be stored under specific climatic conditions, and such facilities are critical before conducting clinical studies. However, in countries such as Mexico, Brazil, and others, lack of clinical supply storage facilities and infrastructure may impede market acceptance of clinical trial supplies services. It is critical, for example, to determine early on if important components of the cold chain must be held in controlled temperature facilities if things are stored. Transportation of clinical supplies from cold storage to clinical sites is difficult, which is projected to limit revenue growth in this market to some extent.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the clinical trial supplies market evolving?
  • What is driving and restraining the clinical trial supplies market?
  • How will each clinical trial supplies submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each clinical trial supplies submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading clinical trial supplies markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the clinical trial supplies projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of clinical trial supplies projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the clinical trial supplies market?
  • Where is the clinical trial supplies market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the clinical trial supplies market today, and over the next 10 years:

  • Our 423-page report provides 187 tables and 272 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the clinical trial supplies market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising clinical trial supplies prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

Location

  • Offshore Clinical Site
  • Domestic Clinical Site

Type

  • Small Molecule Products
  • Biologic Products
  • Medical Devices

Services

  • Manufacturing
    • IMPs and INDs
    • Placebos
    • Assays and Testkits
    • Others
  • Logistics & Distribution
    • Cold Chain Distribution
    • Non-cold Chain
  • Storage & Retention
  • Packaging and Labeling
  • Comparator Sourcing
  • Other CTS Services

Therapeutic Areas

  • Oncology
  • CNS and Mental Disorders
  • Cardiovascular Disease (CVD)
  • Infectious Disease
  • Immunology Disease
  • Blood Disorders
  • Metabolic Disorders
  • Digestive Disorders
  • Other Therapeutic Areas

Phase

  • Phase-I
  • Phase-II
  • Phase-III
  • Phase-IV

End-User

  • Contract Research Organizations
  • Pharmaceutical and Biotechnology Companies
  • Medical Device Companies
  • Other End-Users

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 23 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

MEA

  • South Africa
  • Saudi Arabia
  • Turkey
  • UAE
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Clinical Trial Supplies Market, 2023 to 2033, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth:

  • ADAllen Pharma
  • AmerisourceBergen Corporation
  • Ancillare
  • Biocair
  • Catalent, Inc.
  • Clinigen Group plc
  • Coghlan Group
  • COREX Logistics
  • DHL
  • Durbin
  • Endpoint Clinical
  • Eurofins Scientific SE
  • Inizio (UDG Healthcare plc)
  • IQVIA Inc.
  • KLIFO
  • Liveo Research
  • Lonza
  • Marken (A UPS Company)
  • Movianto
  • Myonex
  • N-SIDE
  • Parexel
  • PCI Pharma Services
  • Piramal Pharma Solutions
  • Recipharm AB
  • Rubicon Research Pvt S.A.
  • Seveillar Clinical Supplies Services
  • Sharp Corporation
  • SIRO Clinpharm
  • Thermo Fisher Scientific Inc.

Overall world revenue for Clinical Trial Supplies Market, 2023 to 2033 in terms of value the market will surpass US$ 2,819.2 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Clinical Trial Supplies Market, 2023 to 2033 report help you?

In summary, our 420+ page report provides you with the following knowledge:

  • Revenue forecasts to 2033 for Clinical Trial Supplies Market, 2023 to 2033, with forecasts for location, type, services, therapeutic areas, phase, and end-user, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 19 key national markets - See forecasts for the Clinical Trial Supplies Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 30 of the major companies involved in the Clinical Trial Supplies Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Clinical Trial Supplies Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Show more
Product Code: PHA1229

Table of Contents

1. Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Clinical Trial Supplies Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Reports
  • 1.10 About

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Increasing Demand for Clinical Trial Outsourcing
      • 3.2.1.2 Rising Demand for Biologics Propelling Growth of Cold Chain Supplies
      • 3.2.1.3 Increasing Investments in the Development of Novel Pharmaceuticals
      • 3.2.1.4 Technology Advancements are Propelling Market Expansion
    • 3.2.2 Market Restraining
      • 3.2.2.1 Availability of Storage Facilities in Each Country
      • 3.2.2.2 Lack of Comparator Sourcing
      • 3.2.2.3 High Costs Associated with Drug Developments
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Increasing Opportunities for Emerging Markets
      • 3.2.3.2 Cut in High Costs Expected to Propel Market Growth
      • 3.2.3.3 Integration of Technical Solutions
  • 3.3 COVID-19 Impact Analysis
  • 3.4 PEST Analysis
    • 3.4.1 Political Factors
    • 3.4.2 Economic Factors
    • 3.4.3 Social Factors
    • 3.4.4 Technological Factors

4 Clinical Trial Supplies Market Analysis by Location

  • 4.1 Key Findings
  • 4.2 Location Segment: Market Attractiveness Index
  • 4.3 Clinical Trial Supplies Market Size Estimation and Forecast by Location
  • 4.4 Offshore Clinical Site
    • 4.4.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 4.4.2 Market Share by Region, 2023 & 2033 (%)
  • 4.5 Domestic Clinical Site
    • 4.5.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 4.5.2 Market Share by Region, 2023 & 2033 (%)

5 Clinical Trial Supplies Market Analysis by Type

  • 5.1 Key Findings
  • 5.2 Type Segment: Market Attractiveness Index
  • 5.3 Clinical Trial Supplies Market Size Estimation and Forecast by Type
  • 5.4 Small Molecule Products
    • 5.4.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 5.4.2 Market Share by Region, 2023 & 2033 (%)
  • 5.5 Biologic Products
    • 5.5.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 5.5.2 Market Share by Region, 2023 & 2033 (%)
  • 5.6 Medical Devices
    • 5.6.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 5.6.2 Market Share by Region, 2023 & 2033 (%)

6 Clinical Trial Supplies Market Analysis by Services

  • 6.1 Key Findings
  • 6.2 Services Segment: Market Attractiveness Index
  • 6.3 Clinical Trial Supplies Market Size Estimation and Forecast by Services
  • 6.4 Manufacturing
    • 6.4.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 6.4.2 Market Share by Region, 2023 & 2033 (%)
    • 6.4.3 IMPs and INDs
    • 6.4.4 Market Size by Region, 2023-2033 (US$ Mn)
    • 6.4.5 Market Share by Region, 2023 & 2033 (%)
    • 6.4.6 Placebos
    • 6.4.7 Market Size by Region, 2023-2033 (US$ Mn)
    • 6.4.8 Market Share by Region, 2023 & 2033 (%)
    • 6.4.9 Assays and Test kits
    • 6.4.10 Market Size by Region, 2023-2033 (US$ Mn)
    • 6.4.11 Market Share by Region, 2023 & 2033 (%)
    • 6.4.12 Others
    • 6.4.13 Market Size by Region, 2023-2033 (US$ Mn)
    • 6.4.14 Market Share by Region, 2023 & 2033 (%)
  • 6.5 Logistics & Distribution
    • 6.5.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 6.5.2 Market Share by Region, 2023 & 2033 (%)
    • 6.5.3 Cold Chain Distribution
    • 6.5.4 Market Size by Region, 2023-2033 (US$ Mn)
    • 6.5.5 Market Share by Region, 2023 & 2033 (%)
    • 6.5.6 Non-cold Chain
    • 6.5.7 Market Size by Region, 2023-2033 (US$ Mn)
    • 6.5.8 Market Share by Region, 2023 & 2033 (%)
  • 6.6 Storage & Retention
    • 6.6.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 6.6.2 Market Share by Region, 2023 & 2033 (%)
  • 6.7 Packaging and Labelling
    • 6.7.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 6.7.2 Market Share by Region, 2023 & 2033 (%)
  • 6.8 Comparator Sourcing
    • 6.8.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 6.8.2 Market Share by Region, 2023 & 2033 (%)
  • 6.9 Other CTS Services
    • 6.9.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 6.9.2 Market Share by Region, 2023 & 2033 (%)

7 Clinical Trial Supplies Market Analysis by Therapeutic Areas

  • 7.1 Key Findings
  • 7.2 Therapeutic Areas Segment: Market Attractiveness Index
  • 7.3 Clinical Trial Supplies Market Size Estimation and Forecast by Therapeutic Areas
  • 7.4 Oncology
    • 7.4.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 7.4.2 Market Share by Region, 2023 & 2033 (%)
  • 7.5 CNS and Mental Disorders
    • 7.5.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 7.5.2 Market Share by Region, 2023 & 2033 (%)
  • 7.6 Cardiovascular Disease (CVD)
    • 7.6.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 7.6.2 Market Share by Region, 2023 & 2033 (%)
  • 7.7 Infectious Disease
    • 7.7.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 7.7.2 Market Share by Region, 2023 & 2033 (%)
  • 7.8 Immunological Diseases
    • 7.8.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 7.8.2 Market Share by Region, 2023 & 2033 (%)
  • 7.9 Blood Disorders
    • 7.9.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 7.9.2 Market Share by Region, 2023 & 2033 (%)
  • 7.10 Metabolic Disorders
    • 7.10.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 7.10.2 Market Share by Region, 2023 & 2033 (%)
  • 7.11 Digestive Disorders
    • 7.11.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 7.11.2 Market Share by Region, 2023 & 2033 (%)
  • 7.12 Other Therapeutic Areas
    • 7.12.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 7.12.2 Market Share by Region, 2023 & 2033 (%)

8 Clinical Trial Supplies Market Analysis by Phase

  • 8.1 Key Findings
  • 8.2 Phase Segment: Market Attractiveness Index
  • 8.3 Clinical Trial Supplies Market Size Estimation and Forecast by Phase
  • 8.4 Phase-I
    • 8.4.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 8.4.2 Market Share by Region, 2023 & 2033 (%)
  • 8.5 Phase-II
    • 8.5.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 8.5.2 Market Share by Region, 2023 & 2033 (%)
  • 8.6 Phase-III
    • 8.6.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 8.6.2 Market Share by Region, 2023 & 2033 (%)
  • 8.7 Phase-IV
    • 8.7.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 8.7.2 Market Share by Region, 2023 & 2033 (%)

9 Clinical Trial Supplies Market Analysis by End-User

  • 9.1 Key Findings
  • 9.2 End-User Segment: Market Attractiveness Index
  • 9.3 Clinical Trial Supplies Market Size Estimation and Forecast by End-User
  • 9.4 Contract Research Organizations
    • 9.4.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 9.4.2 Market Share by Region, 2023 & 2033 (%)
  • 9.5 Pharmaceutical and Biotechnology Companies
    • 9.5.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 9.5.2 Market Share by Region, 2023 & 2033 (%)
  • 9.6 Medical Device Companies
    • 9.6.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 9.6.2 Market Share by Region, 2023 & 2033 (%)
  • 9.7 Other End-Users
    • 9.7.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 9.7.2 Market Share by Region, 2023 & 2033 (%)

10 Clinical Trial Supplies Market Analysis by Region

  • 10.1 Key Findings
  • 10.2 Regional Market Size Estimation and Forecast

11 North America Clinical Trial Supplies Market Analysis

  • 11.1 Key Findings
  • 11.2 North America Clinical Trial Supplies Market Attractiveness Index
  • 11.3 North America Clinical Trial Supplies Market by Country, 2023, 2028 & 2033 (US$ bn)
  • 11.4 North America Clinical Trial Supplies Market Size Estimation and Forecast by Country
  • 11.5 North America Clinical Trial Supplies Market Size Estimation and Forecast by Location
  • 11.6 North America Clinical Trial Supplies Market Size Estimation and Forecast by Type
  • 11.7 North America Clinical Trial Supplies Market Size Estimation and Forecast by Services
    • 11.7.1 North America Clinical Trial Supplies Market Size Estimation and Forecast by Manufacturing
    • 11.7.2 North America Clinical Trial Supplies Market Size Estimation and Forecast by Logistics & Distribution
  • 11.8 North America Clinical Trial Supplies Market Size Estimation and Forecast by Therapeutic Areas
  • 11.9 North America Clinical Trial Supplies Market Size Estimation and Forecast by Phase
  • 11.10 North America Clinical Trial Supplies Market Size Estimation and Forecast by End-User
  • 11.11 U.S. Clinical Trial Supplies Market Analysis
  • 11.12 Canada Clinical Trial Supplies Market Analysis

12 Europe Clinical Trial Supplies Market Analysis

  • 12.1 Key Findings
  • 12.2 Europe Clinical Trial Supplies Market Attractiveness Index
  • 12.3 Europe Clinical Trial Supplies Market by Country, 2023, 2028 & 2033 (US$ bn)
  • 12.4 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Country
  • 12.5 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Location
  • 12.6 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Type
  • 12.7 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Services
    • 12.7.1 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Manufacturing
    • 12.7.2 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Logistics & Distribution
  • 12.8 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Therapeutic Areas
  • 12.9 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Phase
  • 12.10 Europe Clinical Trial Supplies Market Size Estimation and Forecast by End-User
  • 12.11 Germany Clinical Trial Supplies Market Analysis
  • 12.12 UK Clinical Trial Supplies Market Analysis
  • 12.13 France Clinical Trial Supplies Market Analysis
  • 12.14 Italy Clinical Trial Supplies Market Analysis
  • 12.15 Spain Clinical Trial Supplies Market Analysis
  • 12.16 Russia Clinical Trial Supplies Market Analysis
  • 12.17 Rest of Europe Clinical Trial Supplies Market Analysis

13 Asia Pacific Clinical Trial Supplies Market Analysis

  • 13.1 Key Findings
  • 13.2 Asia Pacific Clinical Trial Supplies Market Attractiveness Index
  • 13.3 Asia Pacific Clinical Trial Supplies Market by Country, 2023, 2028 & 2033 (US$ bn)
  • 13.4 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Country
  • 13.5 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Location
  • 13.6 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Type
  • 13.7 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Services
    • 13.7.1 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Manufacturing
    • 13.7.2 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Logistics & Distribution
  • 13.8 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Therapeutic Areas
  • 13.9 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Phase
  • 13.10 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by End-User
  • 13.11 China Clinical Trial Supplies Market Analysis
  • 13.12 India Clinical Trial Supplies Market Analysis
  • 13.13 Japan Clinical Trial Supplies Market Analysis
  • 13.14 South Korea Clinical Trial Supplies Market Analysis
  • 13.15 Australia Clinical Trial Supplies Market Analysis
  • 13.16 Rest of Asia-Pacific Clinical Trial Supplies Market Analysis

14 Latin America Clinical Trial Supplies Market Analysis

  • 14.1 Key Findings
  • 14.2 Latin America Clinical Trial Supplies Market Attractiveness Index
  • 14.3 Latin America Clinical Trial Supplies Market by Country, 2023, 2028 & 2033 (US$ bn)
  • 14.4 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Country
  • 14.5 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Location
  • 14.6 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Type
  • 14.7 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Services
    • 14.7.1 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Manufacturing
    • 14.7.2 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Logistics & Distribution
  • 14.8 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Therapeutic Areas
  • 14.9 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Phase
  • 14.10 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by End-User
  • 14.11 Brazil Clinical Trial Supplies Market Analysis
  • 14.12 Mexico Clinical Trial Supplies Market Analysis
  • 14.13 Rest of Latin America Clinical Trial Supplies Market Analysis

15 MEA Clinical Trial Supplies Market Analysis

  • 15.1 Key Findings
  • 15.2 MEA Clinical Trial Supplies Market Attractiveness Index
  • 15.3 MEA Clinical Trial Supplies Market by Country, 2023, 2028 & 2033 (US$ bn)
  • 15.4 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Country
  • 15.5 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Location
  • 15.6 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Type
  • 15.7 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Services
    • 15.7.1 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Manufacturing
    • 15.7.2 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Logistics & Distribution
  • 15.8 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Therapeutic Areas
  • 15.9 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Phase
  • 15.10 MEA Clinical Trial Supplies Market Size Estimation and Forecast by End-User
  • 15.11 South Africa Clinical Trial Supplies Market Analysis
  • 15.12 Saudi Arabia Clinical Trial Supplies Market Analysis
  • 15.13 Turkey Clinical Trial Supplies Market Analysis
  • 15.14 UAE Clinical Trial Supplies Market Analysis
  • 15.15 Rest of MEA Clinical Trial Supplies Market Analysis

16 Company Profiles

  • 16.1 Competitive Landscape, 2021
  • 16.2 Strategic Outlook
  • 16.3 Thermo Fisher Scientific Inc.
    • 16.3.1 Company Snapshot
    • 16.3.2 Company Overview
    • 16.3.3 Financial Analysis
      • 16.3.3.1 Net Revenue, 2017-2021
      • 16.3.3.2 R&D, 2017-2021
      • 16.3.3.3 Gross Profit, 2017-2021
      • 16.3.3.4 Regional Market Shares, 2021
    • 16.3.4 Product Benchmarking
    • 16.3.5 Strategic Outlook
  • 16.4 Catalent, Inc.
    • 16.4.1 Company Snapshot
    • 16.4.2 Company Overview
    • 16.4.3 Financial Analysis
      • 16.4.3.1 Net Revenue, 2017-2021
      • 16.4.3.2 EBITDA, 2017-2021
      • 16.4.3.3 Net Income, 2017-2021
      • 16.4.3.4 Regional Market Shares, 2021
    • 16.4.4 Product Benchmarking
    • 16.4.5 Strategic Outlook
  • 16.5 Piramal Pharma Solutions
    • 16.5.1 Company Snapshot
    • 16.5.2 Company Overview
    • 16.5.3 Product Benchmarking
    • 16.5.4 Strategic Outlook
  • 16.6 Eurofins Scientific SE
    • 16.6.1 Company Snapshot
    • 16.6.2 Company Overview
    • 16.6.3 Financial Analysis
      • 16.6.3.1 Net Revenue, 2017-2021
      • 16.6.3.2 Operating Income, 2017-2021
      • 16.6.3.3 EBITDA, 2017-2021
      • 16.6.3.4 Net Income, 2017-2021
      • 16.6.3.5 Regional Market Shares, 2021
    • 16.6.4 Product Benchmarking
  • 16.7 Lonza
    • 16.7.1 Company Snapshot
    • 16.7.2 Company Overview
    • 16.7.3 Financial Analysis
      • 16.7.3.1 Net Revenue, 2017-2021
      • 16.7.3.2 EBIT, 2017-2021
      • 16.7.3.3 Gross Profit, 2017-2021
    • 16.7.4 Product Benchmarking
    • 16.7.5 Strategic Outlook
  • 16.8 Clinigen Group plc
    • 16.8.1 Company Snapshot
    • 16.8.2 Company Overview
    • 16.8.3 Financial Analysis
      • 16.8.3.1 Net Revenue, 2017-2021
      • 16.8.3.2 EBITDA, 2017-2021
      • 16.8.3.3 Net Income, 2017-2021
    • 16.8.4 Product Benchmarking
    • 16.8.5 Strategic Outlook
  • 16.9 AmerisourceBergen Corporation
    • 16.9.1 Company Snapshot
    • 16.9.2 Company Overview
    • 16.9.3 Financial Analysis
      • 16.9.3.1 Net Revenue, 2017-2021
      • 16.9.3.2 Operating Income, 2017-2021
      • 16.9.3.3 EBITDA, 2017-2021
      • 16.9.3.4 Net Income, 2017-2021
    • 16.9.4 Product Benchmarking
    • 16.9.5 Strategic Outlook
  • 16.10 DHL
    • 16.10.1 Company Snapshot
    • 16.10.2 Company Overview
    • 16.10.3 Financial Analysis
      • 16.10.3.1 Net Revenue, 2017-2021
      • 16.10.3.2 EBITDA, 2017-2021
      • 16.10.3.3 Gross Profit, 2017-2021
      • 16.10.3.4 Net Income, 2017-2021
      • 16.10.3.5 Operating Income, 2017-2021
      • 16.10.3.6 Regional Market Share, 2017-2021
    • 16.10.4 Product Benchmarking
    • 16.10.5 Strategic Outlook
  • 16.11 Sharp Corporation
    • 16.11.1 Company Snapshot
    • 16.11.2 Company Overview
    • 16.11.3 Financial Analysis
      • 16.11.3.1 Net Revenue, 2017-2021
      • 16.11.3.2 EBITDA, 2017-2021
      • 16.11.3.3 Net Income, 2017-2021
      • 16.11.3.4 Operating Income, 2017-2021
      • 16.11.3.5 Gross Profit, 2017-2021
    • 16.11.4 Product Benchmarking
    • 16.11.5 Strategic Outlook
  • 16.12 IQVIA Inc.
    • 16.12.1 Company Snapshot
    • 16.12.2 Company Overview
    • 16.12.3 Financial Analysis
      • 16.12.3.1 Net Revenue, 2017-2021
      • 16.12.3.2 EBITDA, 2017-2021
      • 16.12.3.3 Gross Profit, 2017-2021
      • 16.12.3.4 Net Income, 2017-2021
      • 16.12.3.5 Operating Income, 2017-2021
      • 16.12.3.6 Regional Market Share, 2017-2021
    • 16.12.4 Product Benchmarking
    • 16.12.5 Strategic Outlook
  • 16.13 Parexel
    • 16.13.1 Company Snapshot
    • 16.13.2 Company Overview
    • 16.13.3 Product Benchmarking
    • 16.13.4 Strategic Outlook
  • 16.14 Biocair
    • 16.14.1 Company Snapshot
    • 16.14.2 Company Overview
    • 16.14.3 Product Benchmarking
    • 16.14.4 Strategic Outlook
  • 16.15 Liveo Research
    • 16.15.1 Company Snapshot
    • 16.15.2 Company Overview
    • 16.15.3 Product Benchmarking
    • 16.15.4 Strategic Outlook
  • 16.16 Marken (A UPS Company)
    • 16.16.1 Company Snapshot
    • 16.16.2 Company Overview
    • 16.16.3 Product Benchmarking
    • 16.16.4 Strategic Outlook
  • 16.17 PCI Pharma Services
    • 16.17.1 Company Snapshot
    • 16.17.2 Company Overview
    • 16.17.3 Product Benchmarking
    • 16.17.4 Strategic Outlook
  • 16.18 Ancillare
    • 16.18.1 Company Snapshot
    • 16.18.2 Company Overview
    • 16.18.3 Product Benchmarking
    • 16.18.4 Strategic Outlook
  • 16.19 N-SIDE
    • 16.19.1 Company Snapshot
    • 16.19.2 Company Overview
    • 16.19.3 Product Benchmarking
    • 16.19.4 Strategic Outlook
  • 16.20 Rubicon Research Pvt S.A.
    • 16.20.1 Company Snapshot
    • 16.20.2 Company Overview
    • 16.20.3 Product Benchmarking
    • 16.20.4 Strategic Outlook
  • 16.21 Myonex
    • 16.21.1 Company Snapshot
    • 16.21.2 Company Overview
    • 16.21.3 Product Benchmarking
    • 16.21.4 Strategic Outlook
  • 16.22 Endpoint Clinical
    • 16.22.1 Company Snapshot
    • 16.22.2 Company Overview
    • 16.22.3 Product Benchmarking
    • 16.22.4 Strategic Outlook
  • 16.23 Recipharm AB
    • 16.23.1 Company Snapshot
    • 16.23.2 Company Overview
    • 16.23.3 Product Benchmarking
    • 16.23.4 Strategic Outlook
  • 16.24 COREX Logistics
    • 16.24.1 Company Snapshot
    • 16.24.2 Company Overview
    • 16.24.3 Product Benchmarking
  • 16.25 Movianto
    • 16.25.1 Company Snapshot
    • 16.25.2 Company Overview
    • 16.25.3 Product Benchmarking
  • 16.26 Durbin
    • 16.26.1 Company Snapshot
    • 16.26.2 Company Overview
    • 16.26.3 Product Benchmarking
  • 16.27 SIRO Clinpharm
    • 16.27.1 Company Snapshot
    • 16.27.2 Company Overview
    • 16.27.3 Product Benchmarking
  • 16.28 Inizio (UDG Healthcare plc)
    • 16.28.1 Company Snapshot
    • 16.28.2 Company Overview
    • 16.28.3 Product Benchmarking
  • 16.29 KLIFO
    • 16.29.1 Company Snapshot
    • 16.29.2 Company Overview
    • 16.29.3 Product Benchmarking
  • 16.30 ADAllen Pharma
    • 16.30.1 Company Snapshot
    • 16.30.2 Company Overview
    • 16.30.3 Product Benchmarking
  • 16.31 Seveillar Clinical Supplies Services
    • 16.31.1 Company Snapshot
    • 16.31.2 Company Overview
    • 16.31.3 Product Benchmarking
  • 16.32 Coghlan Group
    • 16.32.1 Company Snapshot
    • 16.32.2 Company Overview
    • 16.32.3 Product Benchmarking
    • 16.32.4 Strategic Outlook

17 Conclusion and Recommendations

  • 17.1 Concluding Remarks from
  • 17.2 Recommendations for Market Players
    • 17.2.1 Know Your Contract
    • 17.2.2 Establish Clear Roles And Responsibilities
    • 17.2.3 Create A Symbiotic Relationship
Show more
Product Code: PHA1229

List of Tables

  • Table 1 Clinical Trial Supplies Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
  • Table 2 Global Clinical Trial Supplies Market Forecast by Location, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 3 Offshore Clinical Site Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 4 Domestic Clinical Site Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 5 Global Clinical Trial Supplies Market Forecast by Type, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 6 Small Molecule Products Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR %)
  • Table 7 Biologic Products Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 8 Medical Devices Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR %)
  • Table 9 Global Clinical Trial Supplies Market Forecast by Services, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 10 Manufacturing Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR %)
  • Table 11 IMPs and INDs Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 12 Placebos Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 13 Assays and Testkits Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 14 Others Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 15 Logistics & Distribution Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 16 Cold Chain Distribution Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 17 Non-cold Chain Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 18 Storage & Retention Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 19 Packaging and Labeling Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 20 Comparator Sourcing Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 21 Other CTS Services Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 22 Global Clinical Trial Supplies Market Forecast by Therapeutic Areas, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 23 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 24 CNS and Mental Disorders Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 25 Cardiovascular Disease (CVD) Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 26 Infectious Disease Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 27 Immunology Disease Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 28 Blood Disorders Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR %)
  • Table 29 Metabolic Disorders Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 30 Digestive Disorders Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 31 Other Therapeutic Areas Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR %)
  • Table 32 Global Clinical Trial Supplies Market Forecast by Phase, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 33 Phase-I Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 34 Phase-II Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 35 Phase-III Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 36 Phase-IV Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 37 Global Clinical Trial Supplies Market Forecast by End-User, 2023-2033 (US$ Mn, AGR%, CAGR %)
  • Table 38 Contract Research Organizations Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 39 Pharmaceutical and Biotechnology Companies Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 40 Medical Device Companies Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR %)
  • Table 41 Other End-Users Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 42 Global Clinical Trial Supplies Market Forecast by Region 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 43 North America Clinical Trial Supplies Market Forecast by Country, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 44 North America Clinical Trial Supplies Market Forecast by Location, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 45 North America Clinical Trial Supplies Market Forecast by Type, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 46 North America Clinical Trial Supplies Market Forecast by Services, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 47 North America Clinical Trial Supplies Market Forecast by Manufacturing, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 48 North America Clinical Trial Supplies Market Forecast by Logistics & Distribution, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 49 North America Clinical Trial Supplies Market Forecast by Therapeutic Areas, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 50 North America Clinical Trial Supplies Market Forecast by Phase, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 51 North America Clinical Trial Supplies Market Forecast by End-User, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 52 U.S. Clinical Trial Supplies Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR %)
  • Table 53 Canada Clinical Trial Supplies Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 54 Europe Clinical Trial Supplies Market Forecast by Country, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 55 Europe Clinical Trial Supplies Market Forecast by Location, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 56 Europe Clinical Trial Supplies Market Forecast by Type, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 57 Europe Clinical Trial Supplies Market Forecast by Services, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 58 Europe Clinical Trial Supplies Market Forecast by Manufacturing, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 59 Europe Clinical Trial Supplies Market Forecast by Logistics & Distribution, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 60 Europe Clinical Trial Supplies Market Forecast by Therapeutic Areas, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 61 Europe Clinical Trial Supplies Market Forecast by Phase, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 62 Europe Clinical Trial Supplies Market Forecast by End-User, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 63 Germany Clinical Trial Supplies Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 64 UK Clinical Trial Supplies Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 65 France Clinical Trial Supplies Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 66 Italy Clinical Trial Supplies Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 67 Spain Clinical Trial Supplies Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 68 Russia Clinical Trial Supplies Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 69 Rest of Europe Clinical Trial Supplies Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 70 Asia Pacific Clinical Trial Supplies Market Forecast by Country, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 71 Asia Pacific Clinical Trial Supplies Market Forecast by Location, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 72 Asia Pacific Clinical Trial Supplies Market Forecast by Type, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 73 Asia Pacific Clinical Trial Supplies Market Forecast by Services, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 74 Asia Pacific Clinical Trial Supplies Market Forecast by Manufacturing, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 75 Asia Pacific Clinical Trial Supplies Market Forecast by Logistics & Distribution, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 76 Asia Pacific Clinical Trial Supplies Market Forecast by Therapeutic Areas, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 77 Asia Pacific Clinical Trial Supplies Market Forecast by Phase, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 78 Asia Pacific Clinical Trial Supplies Market Forecast by End-User, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 79 China Clinical Trial Supplies Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 80 India Clinical Trial Supplies Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 81 Japan Clinical Trial Supplies Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 82 South Korea Clinical Trial Supplies Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 83 Australia Clinical Trial Supplies Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 84 Rest of Asia-Pacific Clinical Trial Supplies Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 85 Latin America Clinical Trial Supplies Market Forecast by Country, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 86 Latin America Clinical Trial Supplies Market Forecast by Location, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 87 Latin America Clinical Trial Supplies Market Forecast by Type, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 88 Latin America Clinical Trial Supplies Market Forecast by Services, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 89 Latin America Clinical Trial Supplies Market Forecast by Manufacturing, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 90 Latin America Clinical Trial Supplies Market Forecast by Logistics & Distribution, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 91 Latin America Clinical Trial Supplies Market Forecast by Therapeutic Areas, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 92 Latin America Clinical Trial Supplies Market Forecast by Phase, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 93 Latin America Clinical Trial Supplies Market Forecast by End-User, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 94 Brazil Clinical Trial Supplies Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 95 Mexico Clinical Trial Supplies Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 96 Rest of Latin America Clinical Trial Supplies Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 97 MEA Clinical Trial Supplies Market Forecast by Country, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 98 MEA Clinical Trial Supplies Market Forecast by Location, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 99 MEA Clinical Trial Supplies Market Forecast by Type, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 100 MEA Clinical Trial Supplies Market Forecast by Services, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 101 MEA Clinical Trial Supplies Market Forecast by Manufacturing, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 102 MEA Clinical Trial Supplies Market Forecast by Logistics & Distribution, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 103 MEA Clinical Trial Supplies Market Forecast by Therapeutic Areas, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 104 MEA Clinical Trial Supplies Market Forecast by Phase, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 105 MEA Clinical Trial Supplies Market Forecast by End-User, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 106 South Africa Clinical Trial Supplies Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 107 Saudi Arabia Clinical Trial Supplies Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 108 Turkey Clinical Trial Supplies Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 109 UAE Clinical Trial Supplies Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 110 Rest of MEA Clinical Trial Supplies Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 111 Strategic Outlook
  • Table 112 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 113 Thermo Fisher Scientific Inc.: Product Benchmarking
  • Table 1 Thermo Fisher Scientific Inc.: Strategic Outlook
  • Table 114 Catalent, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 115 Catalent, Inc.: Product Benchmarking
  • Table 116 Catalent, Inc.: Strategic Outlook
  • Table 117 Piramal Pharma Solutions: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 118 Piramal Pharma Solutions: Product Benchmarking
  • Table 119 Piramal Pharma Solutions: Strategic Outlook
  • Table 120 Eurofins Scientific SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 121 Eurofins Scientific SE: Product Benchmarking
  • Table 122 Lonza: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 123 Lonza: Product Benchmarking
  • Table 124 Lonza: Strategic Outlook
  • Table 125 Clinigen Group plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 126 Clinigen Group plc: Product Benchmarking
  • Table 2 Clinigen Group plc: Strategic Outlook
  • Table 127 AmerisourceBergen Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 128 AmerisourceBergen Corporation: Product Benchmarking
  • Table 3 AmerisourceBergen Corporation: Strategic Outlook
  • Table 129 DHL: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 130 DHL: Product Benchmarking
  • Table 131 DHL: Strategic Outlook
  • Table 132 Sharp Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 133 Sharp Corporation: Product Benchmarking
  • Table 4 Sharp Corporation: Strategic Outlook
  • Table 134 IQVIA Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 135 IQVIA Inc.: Product Benchmarking
  • Table 136 IQVIA Inc.: Strategic Outlook
  • Table 137 Parexel: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 138 Parexel: Product Benchmarking
  • Table 139 Parexel: Strategic Outlook
  • Table 140 Biocair: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 141 Biocair: Product Benchmarking
  • Table 142 Biocair: Strategic Outlook
  • Table 143 Liveo Research: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 144 Liveo Research: Product Benchmarking
  • Table 145 Liveo Research: Strategic Outlook
  • Table 146 Marken (A UPS Company): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 147 Marken (A UPS Company): Product Benchmarking
  • Table 148 Marken (A UPS Company): Strategic Outlook
  • Table 149 PCI Pharma Services: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 150 PCI Pharma Services: Product Benchmarking
  • Table 151 PCI Pharma Services: Strategic Outlook
  • Table 152 Ancillare: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 153 Ancillare: Product Benchmarking
  • Table 154 Ancillare: Strategic Outlook
  • Table 155 N-SIDE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 156 N-SIDE: Product Benchmarking
  • Table 157 N-SIDE: Strategic Outlook
  • Table 158 Rubicon Research Pvt S.A.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 159 Rubicon Research Pvt S.A.: Product Benchmarking
  • Table 160 Rubicon Research Pvt S.A.: Strategic Outlook
  • Table 161 Myonex: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 162 Myonex: Product Benchmarking
  • Table 163 Myonex: Strategic Outlook
  • Table 164 Endpoint Clinical: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 165 Endpoint Clinical: Product Benchmarking
  • Table 166 Endpoint Clinical: Strategic Outlook
  • Table 167 Recipharm AB: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 168 Recipharm AB: Product Benchmarking
  • Table 5 Recipharm AB: Strategic Outlook
  • Table 169 COREX Logistics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 170 COREX Logistics: Product Benchmarking
  • Table 171 Movianto: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 172 Movianto: Product Benchmarking
  • Table 173 Durbin: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 174 Durbin: Product Benchmarking
  • Table 175 SIRO Clinpharm: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 176 SIRO Clinpharm: Product Benchmarking
  • Table 177 Inizio (UDG Healthcare plc): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 178 Inizio (UDG Healthcare plc): Product Benchmarking
  • Table 179 KLIFO: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 180 KLIFO: Product Benchmarking
  • Table 181 ADAllen Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 182 ADAllen Pharma: Product Benchmarking
  • Table 183 Seveillar Clinical Supplies Services: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 184 Seveillar Clinical Supplies Services: Product Benchmarking
  • Table 185 Coghlan Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 186 Coghlan Group: Product Benchmarking
  • Table 187 Coghlan Group: Strategic Outlook
  •  

List of Figures

  • Figure 1 Clinical Trial Supplies Market Segmentation
  • Figure 2 Clinical Trial Supplies Market by Location: Market Attractiveness Index
  • Figure 3 Clinical Trial Supplies Market by Type: Market Attractiveness Index
  • Figure 4 Clinical Trial Supplies Market by Services: Market Attractiveness Index
  • Figure 5 Clinical Trial Supplies Market by Therapeutic Areas: Market Attractiveness Index
  • Figure 6 Clinical Trial Supplies Market by Phase: Market Attractiveness Index
  • Figure 7 Clinical Trial Supplies Market by End-User: Market Attractiveness Index
  • Figure 8 Clinical Trial Supplies Market Attractiveness Index by Region
  • Figure 9 Clinical Trial Supplies Market: Market Dynamics
  • Figure 10 COVID Impact Analysis: Clinical Trial Supplies Market Recovery Scenarios
  • Figure 11 Clinical Trial Supplies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): "V" Shaped Recovery Scenario
  • Figure 12 Clinical Trial Supplies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): "V" Shaped Recovery
  • Figure 13 Clinical Trial Supplies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): "U" Shaped Recovery Scenario
  • Figure 14 Clinical Trial Supplies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): "U" Shaped Recovery
  • Figure 15 Clinical Trial Supplies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): "W" Shaped Recovery Scenario
  • Figure 16 Clinical Trial Supplies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): "W" Shaped Recovery
  • Figure 17 Clinical Trial Supplies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): "L" Shaped Recovery Scenario
  • Figure 18 Clinical Trial Supplies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): "L" Shaped Recovery
  • Figure 19 Clinical Trial Supplies Market: PEST Analysis
  • Figure 20 Clinical Trial Supplies Market by Location: Market Attractiveness Index
  • Figure 21 Clinical Trial Supplies Market Forecast by Location, 2023-2033 (US$ million)
  • Figure 22 Clinical Trial Supplies Market Share Forecast by Location, 2023, 2028, 2033 (%)
  • Figure 23 Offshore Clinical Site Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 24 Offshore Clinical Site Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 25 Offshore Clinical Site Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 26 Offshore Clinical Site Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 27 Clinical Trial Supplies Market by Type: Market Attractiveness Index
  • Figure 28 Clinical Trial Supplies Market Forecast by Type, 2023-2033 (US$ million)
  • Figure 29 Clinical Trial Supplies Market Share Forecast by Type, 2023, 2028, 2033 (%)
  • Figure 30 Small Molecule Products Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 31 Small Molecule Products Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 32 Biologic Products Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 33 Biologic Products Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 34 Medical Devices Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 35 Medical Devices Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 36 Clinical Trial Supplies Market by Services: Market Attractiveness Index
  • Figure 37 Clinical Trial Supplies Market Forecast by Services, 2023-2033 (US$ million)
  • Figure 38 Clinical Trial Supplies Market Share Forecast by Services, 2023, 2028, 2033 (%)
  • Figure 39 Manufacturing Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 40 Manufacturing Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 41 IMPs and INDs Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 42 IMPs and INDs Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 43 Placebos Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 44 Placebos Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 45 Assays and Testkits Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 46 Assays and Testkits Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 47 Others Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 48 Others Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 49 Logistics & Distribution Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 50 Logistics & Distribution Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 51 Cold Chain Distribution Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 52 Cold Chain Distribution Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 53 Non-cold Chain Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 54 Non-cold Chain Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 55 Logistics & Distribution Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 56 Storage & Retention Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 57 Packaging and Labeling Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 58 Packaging and Labeling Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 59 Comparator Sourcing Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 60 Comparator Sourcing Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 61 Other CTS Services Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 62 Other CTS Services Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 63 Clinical Trial Supplies Market by Therapeutic Areas: Market Attractiveness Index
  • Figure 64 Clinical Trial Supplies Market Forecast by Therapeutic Areas, 2023-2033 (US$ million)
  • Figure 65 Clinical Trial Supplies Market Share Forecast by Therapeutic Areas, 2023, 2028, 2033 (%)
  • Figure 66 Oncology Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 67 Oncology Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 68 CNS and Mental Disorders Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 69 CNS and Mental Disorders Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 70 Cardiovascular Disease (CVD) Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 71 Cardiovascular Disease (CVD) Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 72 Cardiovascular Disease (CVD) Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 73 Cardiovascular Disease (CVD) Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 74 Oncology Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 75 Oncology Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 76 Blood Disorders Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 77 Blood Disorders Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 78 Metabolic Disorders Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 79 Metabolic Disorders Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 80 Metabolic Disorders Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 81 Digestive Disorders Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 82 Other Therapeutic Areas Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 83 Other Therapeutic Areas Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 84 Clinical Trial Supplies Market by Phase: Market Attractiveness Index
  • Figure 85 Clinical Trial Supplies Market Forecast by Phase, 2023-2033 (US$ million)
  • Figure 86 Clinical Trial Supplies Market Share Forecast by Phase, 2023, 2028, 2033 (%)
  • Figure 87 Phase-I Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 88 Phase-I Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 89 Phase-II Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 90 Phase-II Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 91 Phase-III Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 92 Phase-III Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 93 Phase-IV Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 94 Phase-IV Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 95 Clinical Trial Supplies Market by End-User: Market Attractiveness Index
  • Figure 96 Clinical Trial Supplies Market Forecast by End-User, 2023-2033 (US$ million)
  • Figure 97 Clinical Trial Supplies Market Share Forecast by End-User, 2023, 2028, 2033 (%)
  • Figure 98 Phase-I Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 99 Phase-I Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 100 Pharmaceutical and Biotechnology Companies Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 101 Pharmaceutical and Biotechnology Companies Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 102 Medical Device Companies Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 103 Medical Device Companies Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 104 Medical Device Companies Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 105 Other End-Users Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 106 Clinical Trial Supplies Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%)
  • Figure 107 Clinical Trial Supplies Market Share Forecast by Region 2023, 2028, 2033(%)
  • Figure 108 Clinical Trial Supplies Market by Region, 2023-2033 (US$ Mn)
  • Figure 109 North America Clinical Trial Supplies Market Attractiveness Index
  • Figure 110 North America Clinical Trial Supplies Market by Region, 2023, 2028 & 2033 (US$ million)
  • Figure 111 North America Clinical Trial Supplies Market Forecast by Country, 2023-2033 (US$ million)
  • Figure 112 North America Clinical Trial Supplies Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 113 North America Clinical Trial Supplies Market Forecast by Location, 2023-2033 (US$ million)
  • Figure 114 North America Clinical Trial Supplies Market Share Forecast by Location, 2023 & 2033 (%)
  • Figure 115 North America Clinical Trial Supplies Market Forecast by Type, 2023-2033 (US$ million)
  • Figure 116 North America Clinical Trial Supplies Market Share Forecast by Type, 2023 & 2033 (%)
  • Figure 117 North America Clinical Trial Supplies Market Forecast by Services, 2023-2033 (US$ million)
  • Figure 118 North America Clinical Trial Supplies Market Share Forecast by Services, 2023 & 2033 (%)
  • Figure 119 North America Clinical Trial Supplies Market Forecast by Manufacturing, 2023-2033 (US$ million)
  • Figure 120 North America Clinical Trial Supplies Market Share Forecast by Manufacturing, 2023 & 2033 (%)
  • Figure 121 North America Clinical Trial Supplies Market Forecast by Logistics & Distribution, 2023-2033 (US$ million)
  • Figure 122 North America Clinical Trial Supplies Market Share Forecast by Logistics & Distribution, 2023 & 2033 (%)
  • Figure 123 North America Clinical Trial Supplies Market Forecast by Therapeutic Areas, 2023-2033 (US$ million)
  • Figure 124 North America Clinical Trial Supplies Market Share Forecast by Therapeutic Areas, 2023 & 2033 (%)
  • Figure 125 North America Clinical Trial Supplies Market Forecast by Phase, 2023-2033 (US$ million)
  • Figure 126 North America Clinical Trial Supplies Market Share Forecast by Phase, 2023 & 2033 (%)
  • Figure 127 North America Clinical Trial Supplies Market Forecast by End-User, 2023-2033 (US$ million)
  • Figure 128 North America Clinical Trial Supplies Market Share Forecast by Phase, 2023 & 2033 (%)
  • Figure 129 U.S. Clinical Trial Supplies Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 130 Canada Clinical Trial Supplies Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 131 Europe Clinical Trial Supplies Market Attractiveness Index
  • Figure 132 Europe Clinical Trial Supplies Market by Region, 2023, 2028 & 2033 (US$ million)
  • Figure 133 Europe Clinical Trial Supplies Market Forecast by Country, 2023-2033 (US$ million)
  • Figure 134 Europe Clinical Trial Supplies Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 135 Europe Clinical Trial Supplies Market Forecast by Location, 2023-2033 (US$ million)
  • Figure 136 Europe Clinical Trial Supplies Market Share Forecast by Location, 2023 & 2033 (%)
  • Figure 137 Europe Clinical Trial Supplies Market Forecast by Type, 2023-2033 (US$ million)
  • Figure 138 Europe Clinical Trial Supplies Market Share Forecast by Type, 2023 & 2033 (%)
  • Figure 139 Europe Clinical Trial Supplies Market Forecast by Services, 2023-2033 (US$ million)
  • Figure 140 Europe Clinical Trial Supplies Market Share Forecast by Services, 2023 & 2033 (%)
  • Figure 141 Europe Clinical Trial Supplies Market Forecast by Manufacturing, 2023-2033 (US$ million)
  • Figure 142 Europe Clinical Trial Supplies Market Share Forecast by Manufacturing, 2023 & 2033 (%)
  • Figure 143 Europe Clinical Trial Supplies Market Forecast by Logistics & Distribution, 2023-2033 (US$ million)
  • Figure 144 Europe Clinical Trial Supplies Market Share Forecast by Logistics & Distribution, 2023 & 2033 (%)
  • Figure 145 Europe Clinical Trial Supplies Market Forecast by Therapeutic Areas, 2023-2033 (US$ million)
  • Figure 146 Europe Clinical Trial Supplies Market Share Forecast by Therapeutic Areas, 2023 & 2033 (%)
  • Figure 147 Europe Clinical Trial Supplies Market Forecast by Phase, 2023-2033 (US$ million)
  • Figure 148 Europe Clinical Trial Supplies Market Share Forecast by Phase, 2023 & 2033 (%)
  • Figure 149 Europe Clinical Trial Supplies Market Forecast by End-User, 2023-2033 (US$ million)
  • Figure 150 Europe Clinical Trial Supplies Market Share Forecast by Phase, 2023 & 2033 (%)
  • Figure 151 Germany Clinical Trial Supplies Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 152 UK Clinical Trial Supplies Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 153 France Clinical Trial Supplies Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 154 Italy Clinical Trial Supplies Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 155 Spain Clinical Trial Supplies Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 156 Russia Clinical Trial Supplies Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 157 Rest of Europe Clinical Trial Supplies Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 158 Asia Pacific Clinical Trial Supplies Market Attractiveness Index
  • Figure 159 Asia Pacific Clinical Trial Supplies Market by Region, 2023, 2028 & 2033 (US$ million)
  • Figure 160 Asia Pacific Clinical Trial Supplies Market Forecast by Country, 2023-2033 (US$ million)
  • Figure 161 Asia Pacific Clinical Trial Supplies Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 162 Asia Pacific Clinical Trial Supplies Market Forecast by Location, 2023-2033 (US$ million)
  • Figure 163 Asia Pacific Clinical Trial Supplies Market Share Forecast by Location, 2023 & 2033 (%)
  • Figure 164 Asia Pacific Clinical Trial Supplies Market Forecast by Type, 2023-2033 (US$ million)
  • Figure 165 Asia Pacific Clinical Trial Supplies Market Share Forecast by Type, 2023 & 2033 (%)
  • Figure 166 Asia Pacific Clinical Trial Supplies Market Forecast by Services, 2023-2033 (US$ million)
  • Figure 167 Asia Pacific Clinical Trial Supplies Market Share Forecast by Services, 2023 & 2033 (%)
  • Figure 168 Asia Pacific Clinical Trial Supplies Market Forecast by Manufacturing, 2023-2033 (US$ million)
  • Figure 169 Asia Pacific Clinical Trial Supplies Market Share Forecast by Manufacturing, 2023 & 2033 (%)
  • Figure 170 Asia Pacific Clinical Trial Supplies Market Forecast by Logistics & Distribution, 2023-2033 (US$ million)
  • Figure 171 Asia Pacific Clinical Trial Supplies Market Share Forecast by Logistics & Distribution, 2023 & 2033 (%)
  • Figure 172 Asia Pacific Clinical Trial Supplies Market Forecast by Therapeutic Areas, 2023-2033 (US$ million)
  • Figure 173 Asia Pacific Clinical Trial Supplies Market Share Forecast by Therapeutic Areas, 2023 & 2033 (%)
  • Figure 174 Asia Pacific Clinical Trial Supplies Market Forecast by Phase, 2023-2033 (US$ million)
  • Figure 175 Asia Pacific Clinical Trial Supplies Market Share Forecast by Phase, 2023 & 2033 (%)
  • Figure 176 Asia Pacific Clinical Trial Supplies Market Forecast by End-User, 2023
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!